-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Downgrades Passage Bio to Hold

Benzinga·04/21/2026 16:21:52
Listen to the news
TD Cowen analyst Brendan Smith downgrades Passage Bio (NASDAQ:PASG) from Buy to Hold.